← Back to Search

Communication Skills Training for Kidney Transplant (EPPComm Trial)

N/A

Waitlist Available

Led By Francis Weng, MD

Research Sponsored by Temple University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, 4 years

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to study the communication between Black and Caucasian patients and their transplant providers during transplant evaluation consultations. They want to see how different types of communication affect patient outcomes and living donor transplant outcomes. The

Who is the study for?

This trial is for Black or Caucasian adults who speak English and are being evaluated for a kidney transplant at specific hospitals. It includes patients with limited English if they use a translator, but not those treated offsite or who've had previous transplants. Transplant team members involved in patient evaluations can also participate unless they decline audio recording of consultations.

What is being tested?

The study aims to improve how transplant providers communicate with patients about living donor kidney transplants. It will record consultations, survey participants, and then train providers based on these insights. The effect of this training on the number of living donor inquiries, evaluations, and actual transplants will be measured.

What are the potential side effects?

Since this trial focuses on communication training rather than medical treatment, there are no direct physical side effects expected from participating in the study itself.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, 4 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, 4 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, 4 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Live donor evaluations

Live donor inquiries

Live donor kidney transplant

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: EPPCom Provider TrainingExperimental Treatment1 Intervention

A highly engaging and interactive 60-minute, in-person communication skills training program will be developed as part of this project. Participating transplant providers will complete a brief online survey before (pre) and after (post) participating in the training.

Do I qualify?Apply below to find out